For future investigations, we suggest neurofilament light chain (NfL) in blood or CSF, which is another widely used fluid biomarker of neurodegeneration, not specific to AD and may be more appropriate for the “N” classification.39, 40, 41, 42. This evidence concerns the gene NEFL and Alzheimer disease.